Pancreatic Cancer Research

ResearcherMoffitt Cancer CenterNo recent work listed

James F. Helm

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-7402-9467; OpenAlex author ID A5109878314. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2011: 2 papers · 2012: 1 paper

Papers 3

  1. SLC5A8 nuclear translocation and loss of expression are associated with poor outcome in pancreatic ductal adenocarcinoma. Co-author DOI 10.1097/mpa.0b013e31823f429f↗
  2. Neoadjuvant GTX chemotherapy and IMRT-based chemoradiation for borderline resectable pancreatic cancer. Co-author DOI 10.1002/jso.21954↗
  3. Down-regulation of Bax-interacting factor 1 in human pancreatic ductal adenocarcinoma. First author DOI 10.1097/mpa.0b013e318205eb03↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mokenge Peter Malafa · 3 shared papers, 2011–2012 · strength 0.09
  2. Domenico Coppola · 2 shared papers, 2011–2012 · strength 0.07
  3. Barbara Ann Centeno · 2 shared papers, 2011–2012 · strength 0.06
  4. Hong‐Gang Wang · 1 shared paper, 2011 · strength 0.03
  5. Dung‐Tsa Chen · 1 shared paper, 2012 · strength 0.03
  6. Vadivel Ganapathy · 1 shared paper, 2012 · strength 0.03
  7. Jong Y. Park · 1 shared paper, 2012 · strength 0.03
  8. Gregory M. Springett · 1 shared paper, 2011 · strength 0.03
  9. Manish R. Patel · 1 shared paper, 2011 · strength 0.03
  10. Sarah E. Hoffe · 1 shared paper, 2011 · strength 0.03
  11. Jason B. Klapman · 1 shared paper, 2011 · strength 0.03
  12. Pamela Joy Hodul · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.